Participant safety, without the paperwork lag.
TAET centralizes adverse event intake, review and reporting so sponsors, CROs and investigators can act quickly and stay compliant across every study site.
Built for regulated research
From decentralized studies to complex oncology protocols, TAET keeps the safety picture current and defensible.
Centralized safety intake
Capture events from investigator portals and mobile reporting, routed automatically to the right reviewers.
Compliance automation
Templated submissions, notifications and narratives with complete audit trails and electronic signatures.
Risk analytics
See safety trends and cohort-level risk on dashboards ready for Data Safety Monitoring Boards.
Connected oversight
Role-based views keep sponsors, CROs, investigators and DSMBs working from the same evidence.
GCP-ready
A validated, audit-ready platform designed to support Good Clinical Practice.
Participant-first
Faster review cycles mean safety signals are acted on in hours, not days.
Every phase of trial safety
Site readiness
Training logs, delegation forms and activation checklists, so sites can report from day one.
Signal detection
Alerts for serious adverse events and protocol deviations, with configurable routing and escalation.
Review & reporting
Coordinate medical monitors, DSMBs and regulatory submissions in one workflow.
Continuous improvement
Feed findings back into risk assessments, SOPs and future study designs.
See how TAET supports safer trials
Talk to us about onboarding studies and aligning TAET with your regulatory strategy.